These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3597999)

  • 21. Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic study.
    Kim SG; Aboaf AP; Roth J; Ferrick K; Fisher JD
    Am Heart J; 1991 Jan; 121(1 Pt 1):77-80. PubMed ID: 1985381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs?].
    Steinbeck G
    Z Gesamte Inn Med; 1992 May; 47(5):195-201. PubMed ID: 1615729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
    van Hemel NM; Kingma JH; Defauw JJ; Hoogteijling-van Dusseldorp E; Kelder JC; Beukema WP; Vermeulen FE
    Eur Heart J; 1996 Apr; 17(4):564-73. PubMed ID: 8733090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpected, sustained ventricular tachyarrhythmia after cardiac operations.
    Tam SK; Miller JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1991 Dec; 102(6):883-9. PubMed ID: 1960992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease.
    Lampert S; Lown B; Graboys TB; Podrid PJ; Blatt CM
    Am J Cardiol; 1988 Apr; 61(10):791-7. PubMed ID: 3354443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs.
    Graboys TB; Lown B; Podrid PJ; DeSilva R
    Am J Cardiol; 1982 Sep; 50(3):437-43. PubMed ID: 6180622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups.
    Poole JE; Mathisen TL; Kudenchuk PJ; McAnulty JH; Swerdlow CD; Bardy GH; Greene HL
    J Am Coll Cardiol; 1990 Sep; 16(3):657-65. PubMed ID: 2387939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant metoprolol improves efficacy of class I antiarrhythmic drugs in patients with inducible sustained monomorphic ventricular tachycardia.
    Brodsky MA; Chough SP; Allen BJ; Capparelli EV; Orlov MV; Caudillo G
    Am Heart J; 1992 Sep; 124(3):629-35. PubMed ID: 1514490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia.
    Mendes L; Podrid PJ; Fuchs T; Franklin S
    J Am Coll Cardiol; 1991 May; 17(6):1396-402. PubMed ID: 2016457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of malignant ventricular arrhythmia guided by electrophysiologic study].
    Brandão L; Carpinteiro L; Sousa J; Vagueiro MC
    Acta Med Port; 1998 Jan; 11(1):9-16. PubMed ID: 9580363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation.
    Platia EV; Reid PR
    J Am Coll Cardiol; 1984 Sep; 4(3):493-500. PubMed ID: 6470328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of Holter monitoring in selecting pharmacologic therapy for patients with sustained monomorphic ventricular tachycardia: studies in patients in whom no effective pharmacologic therapy could be determined by electrophysiologic study.
    Niwano S; Furushima H; Taneda K; Abe A; Ohira K; Aizawa Y
    Jpn Circ J; 1998 May; 62(5):347-52. PubMed ID: 9626902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P; Newman D; Berman N; Hardy J; Mitchell J
    J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
    Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
    Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.